Shaping the Next Era of Cardiac Ablation: Clinical Insights From Early Adopters
Real-world perspectives from PulseSelect™ and Affera™
With lots of new pulsed-field ablation (PFA) technology becoming available, one key question emerges: How are these systems performing in real-world clinical practice? This on-demand version of the session takes you inside the lab to share practical perspectives from physicians at the forefront of PFA adoption.
Chaired by Dr Jack McCready (University Hospitals Sussex NHS Foundation Trust, UK), the session features insightful presentations and discussions with Dr Richard Balasubramaniam (Royal Bournemouth Hospital, UK) and Dr Sandeep Panikker (University Hospital Coventry, UK) as they explore the next era of cardiac pulsed-field ablation (PFA).
Dr Panikker presents his experience with the PulseSelect™ PFA system, a technology setting a new standard in safety for paroxysmal and persistent atrial fibrillation ablation, supported by 15 years of robust preclinical and clinical evidence.1
Following this, Dr Balasubramaniam shares real-world insights from using the Affera mapping and ablation system. The Affera Sphere-9™ introduces an all-in-one solution that combines high-resolution mapping with dual-energy ablation, enabling electrophysiologists to seamlessly transition between pulsed-field and radiofrequency modalities within a single system.
Catch up on the session at your convenience, to see how PFA systems can be integrated into everyday clinical workflows and explore how these technologies are reshaping efficiency, safety, and outcomes in cardiac ablation.
Excerpts from the session
'PFA of course is a novel technology and it offers potential advantages over our current thermal ablation in terms of safety…Certainly, the ablation delivery is very much quicker' - Dr Sandeep Panikker
'We found [Affera Sphere-9] to be quick, safe, effective, and really very easy to use…It is consistent, so you can book cases and not feel that one’s going to take forever. This catheter is so versatile that when something turns up, you feel able to tackle that as well…' - Dr Richard Balasubramaniam
Key Learning Objectives
- To understand that PulseSelect offers the safest PFA with the most durable lesions
- To appreciate that Affera redefines all-in-one mapping and dual energy ablation
- To learn from real-world examples of how to integrate these technologies into clinical practice, and absorb best practices and recommendations
Target Audience
- Consultant Cardiologists
- Electrophysiologists
- Cardiac Nurses
- Cardiac Physiologists
- Healthcare Managers
More from this programme
Part 1
Introduction
Dr Jack McCready introduces the webinar and shares an overview of his personal experience of PFA at his centre.
| 1 session | |
| Introduction | Watch now |
Part 2
Pulseselect™ - Real-World Case And Learnings From Coventry
Dr Panikker presents his experience with the PulseSelect™ PFA system, a technology setting a new standard in safety for paroxysmal and persistent atrial fibrillation ablation.
Part 3
Affera Sphere-9™ - Real-World Case And Learnings From Bournemouth
Dr Balasubramaniam shares real-world insights from using the Affera mapping and ablation system.
Part 4
Q&A and Panel Discussion
Dr Jack McCready chairs an engaging panel discussion with the faculty, answering questions from the audience.
| 1 session | |
| Q&A and Panel Discussion | Watch now |
Faculty Biographies
Jack McCready
Consultant Cardiologist
Dr Jack McCready is a highly respected consultant cardiologist based in Brighton and Worthing, West Sussex. He is renowned for his expertise in atrial fibrillation and arrhythmia and also specialises in ablation, pacemakers and implantable cardioverter defibrillators (ICD).
Dr McCready qualified in medicine from the University of London in 2000, following his completion of a clinical fellowship at University College London Hospitals NHS Foundation Trust. He was awarded membership of the Royal College of Physicians in 2003 and completed his specialist training in cardiology in 2010. That same year, he was appointed as a consultant cardiologist at Brighton and Sussex University Hospitals NHS Trust. Dr McCready sees private patients at Nuffield Health Brighton Hospital, Goring Hall Hospital in Worthing and Spire Montefiore Hospital in Hove.
Sandeep Panikker
Consultant Cardiologist and Electrophysiologist
Dr Sandeep Panikker is an honorary consultant at Royal Brompton Hospital, a consultant cardiologist and electrophysiologist at University Hospitals Coventry and Warwickshire and BMI Meridian Coventry.
He completed his medical training at Imperial College School of Medicine at St. Mary’s Hospital in 2002, with distinction in all subjects. He then subspecialised in cardiac electrophysiology at St Bartholomew’s and Royal Brompton hospitals.
In 2016, he completed a PhD at Imperial College, focused on atrial fibrillation and the left atrial appendage during which he achieved several high profile publications and awards.
As joint lead for the left atrial appendage closure training programme at the Royal Brompton Hospital, he enjoys his work mentoring and training fellow consultants in the UK and Europe. He also leads the left atrial appendage closure programme at University Hospital Coventry.
Richard Balasubramaniam
Consultant Cardiologist & EP, and Clinical Lead for Cardiac Rhythm Management at University Hospitals Dorset
Dr Richard Balasubramaniam is a Consultant Cardiologist & EP, and Clinical Lead for Cardiac Rhythm Management at University Hospitals Dorset, UK.
Dr Balasubramaniam graduated from the University of Birmingham in 1996, having been a winner of the Aesculapius Prize for services to medicine, and trained in Cardiology at Papworth Hospital, Cambridge before pursuing a fellowship in Electrophysiology under Professor Jonathan Kalman at the Royal Melbourne Hospital in Melbourne, Australia, one of the world’s leading centres in cardiac electrophysiology. During the training, he completed a PhD at Cambridge University in ventricular arrhythmias in genetically modified murine models of arrhythmogenesis and maintained an interest in the management of patients with channelopathies and aborted sudden cardiac death. He was appointed as a Consultant Cardiologist and Electrophysiologist at the Royal Bournemouth Hospital in December 2008.
Comments